FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213018166> ?p ?o ?g. }

• W3213018166 abstract "Acta OphthalmologicaEarly View Letter to the Editor Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy? Ani Korhonen, Ani Korhonen orcid.org/0000-0002-6864-4596 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorErika Gucciardo, Erika Gucciardo orcid.org/0000-0003-4481-8798 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorKaisa Lehti, Kaisa Lehti orcid.org/0000-0001-9110-8719 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden Department of Biomedical Laboratory Science, Norwegian University of Science and Technology, Trondheim, NorwaySearch for more papers by this authorSirpa Loukovaara, Corresponding Author Sirpa Loukovaara sirpa.loukovaara@hus.fi orcid.org/0000-0002-2506-3900 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Unit of Vitreoretinal Surgery, Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland Correspondence: Sirpa Loukovaara Individualized Drug Therapy Research Program Faculty of Medicine University of Helsinki Helsinki Finland Tel: +358504271566 Fax: 09-47175147 Email: sirpa.loukovaara@hus.fiSearch for more papers by this author Ani Korhonen, Ani Korhonen orcid.org/0000-0002-6864-4596 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorErika Gucciardo, Erika Gucciardo orcid.org/0000-0003-4481-8798 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, FinlandSearch for more papers by this authorKaisa Lehti, Kaisa Lehti orcid.org/0000-0001-9110-8719 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden Department of Biomedical Laboratory Science, Norwegian University of Science and Technology, Trondheim, NorwaySearch for more papers by this authorSirpa Loukovaara, Corresponding Author Sirpa Loukovaara sirpa.loukovaara@hus.fi orcid.org/0000-0002-2506-3900 Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Unit of Vitreoretinal Surgery, Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland Correspondence: Sirpa Loukovaara Individualized Drug Therapy Research Program Faculty of Medicine University of Helsinki Helsinki Finland Tel: +358504271566 Fax: 09-47175147 Email: sirpa.loukovaara@hus.fiSearch for more papers by this author First published: 08 November 2021 https://doi.org/10.1111/aos.15058 This study was supported by grants from the Sigrid Juselius Foundation (KL), Karolinska Institutet (KL), Finnish Eye Foundation (SL), Mary and Georg C. Ehrnrooth Foundation (SL), HUCH Clinical Research Grants (TYH2016230, TYH2019232, TYH2020225 and SL), Finnish Medical Foundation (SL) and Paulo Foundation (EG). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation" @default.
• W3213018166 created "2021-11-22" @default.
• W3213018166 creator A5006979502 @default.
• W3213018166 creator A5041658177 @default.
• W3213018166 creator A5075159309 @default.
• W3213018166 creator A5085029945 @default.
• W3213018166 date "2021-11-08" @default.
• W3213018166 modified "2023-10-01" @default.
• W3213018166 title "Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy?" @default.
• W3213018166 cites W2057489557 @default.
• W3213018166 cites W2057622010 @default.
• W3213018166 cites W2162143298 @default.
• W3213018166 cites W3175791609 @default.
• W3213018166 cites W3199411287 @default.
• W3213018166 doi "https://doi.org/10.1111/aos.15058" @default.
• W3213018166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34750980" @default.
• W3213018166 hasPublicationYear "2021" @default.
• W3213018166 type Work @default.
• W3213018166 sameAs 3213018166 @default.
• W3213018166 citedByCount "0" @default.
• W3213018166 crossrefType "journal-article" @default.
• W3213018166 hasAuthorship W3213018166A5006979502 @default.
• W3213018166 hasAuthorship W3213018166A5041658177 @default.
• W3213018166 hasAuthorship W3213018166A5075159309 @default.
• W3213018166 hasAuthorship W3213018166A5085029945 @default.
• W3213018166 hasConcept C126322002 @default.
• W3213018166 hasConcept C161191863 @default.
• W3213018166 hasConcept C2776768464 @default.
• W3213018166 hasConcept C41008148 @default.
• W3213018166 hasConcept C512399662 @default.
• W3213018166 hasConcept C71924100 @default.
• W3213018166 hasConceptScore W3213018166C126322002 @default.
• W3213018166 hasConceptScore W3213018166C161191863 @default.
• W3213018166 hasConceptScore W3213018166C2776768464 @default.
• W3213018166 hasConceptScore W3213018166C41008148 @default.
• W3213018166 hasConceptScore W3213018166C512399662 @default.
• W3213018166 hasConceptScore W3213018166C71924100 @default.
• W3213018166 hasFunder F4320310751 @default.
• W3213018166 hasFunder F4320316026 @default.
• W3213018166 hasFunder F4320322315 @default.
• W3213018166 hasFunder F4320323760 @default.
• W3213018166 hasFunder F4320324406 @default.
• W3213018166 hasFunder F4320328032 @default.
• W3213018166 hasIssue "5" @default.
• W3213018166 hasLocation W32130181661 @default.
• W3213018166 hasLocation W32130181662 @default.
• W3213018166 hasOpenAccess W3213018166 @default.
• W3213018166 hasPrimaryLocation W32130181661 @default.
• W3213018166 hasRelatedWork W1989870400 @default.
• W3213018166 hasRelatedWork W1995515455 @default.
• W3213018166 hasRelatedWork W2748952813 @default.
• W3213018166 hasRelatedWork W2889529591 @default.
• W3213018166 hasRelatedWork W2899084033 @default.
• W3213018166 hasRelatedWork W2953633878 @default.
• W3213018166 hasRelatedWork W2981515574 @default.
• W3213018166 hasRelatedWork W3031052312 @default.
• W3213018166 hasRelatedWork W3032375762 @default.
• W3213018166 hasRelatedWork W4232428403 @default.
• W3213018166 hasVolume "100" @default.
• W3213018166 isParatext "false" @default.
• W3213018166 isRetracted "false" @default.
• W3213018166 magId "3213018166" @default.
• W3213018166 workType "article" @default.